Search

Yewebdar T. Tadesse

Examiner (ID: 18610, Phone: (571)272-1238 , Office: P/1717 )

Most Active Art Unit
1717
Art Unit(s)
1734, 1713, 1717, 1792
Total Applications
1806
Issued Applications
1359
Pending Applications
126
Abandoned Applications
345

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19164755 [patent_doc_number] => 11980637 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-14 [patent_title] => Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy [patent_app_type] => utility [patent_app_number] => 17/233802 [patent_app_country] => US [patent_app_date] => 2021-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12146 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17233802 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/233802
Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy Apr 18, 2021 Issued
Array ( [id] => 17943553 [patent_doc_number] => 20220330570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => METHOD AND SYSTEM FOR MANUFACTURING CHILL POPS [patent_app_type] => utility [patent_app_number] => 17/231378 [patent_app_country] => US [patent_app_date] => 2021-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2377 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231378 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/231378
METHOD AND SYSTEM FOR MANUFACTURING CHILL POPS Apr 14, 2021 Abandoned
Array ( [id] => 17355349 [patent_doc_number] => 20220016145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-20 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHY AND OTHER DISORDERS [patent_app_type] => utility [patent_app_number] => 17/222662 [patent_app_country] => US [patent_app_date] => 2021-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18755 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17222662 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/222662
Compositions and methods for treating muscular dystrophy and other disorders Apr 4, 2021 Issued
Array ( [id] => 18232072 [patent_doc_number] => 11596614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-03-07 [patent_title] => Treatment of intrahepatic cholestatic diseases [patent_app_type] => utility [patent_app_number] => 17/221784 [patent_app_country] => US [patent_app_date] => 2021-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4280 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221784 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/221784
Treatment of intrahepatic cholestatic diseases Apr 2, 2021 Issued
Array ( [id] => 20301268 [patent_doc_number] => 12447238 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-10-21 [patent_title] => Antimicrobial tubular conduits [patent_app_type] => utility [patent_app_number] => 17/907290 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 6293 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907290 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/907290
Antimicrobial tubular conduits Mar 25, 2021 Issued
Array ( [id] => 18449452 [patent_doc_number] => 20230190728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => NEW THERAPEUTIC USES OF COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/913379 [patent_app_country] => US [patent_app_date] => 2021-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29831 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913379 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/913379
NEW THERAPEUTIC USES OF COMPOUNDS Mar 24, 2021 Pending
Array ( [id] => 18595333 [patent_doc_number] => 20230270121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => NOVEL ORGANIC FUNGICIDE [patent_app_type] => utility [patent_app_number] => 18/006701 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5298 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006701 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/006701
NOVEL ORGANIC FUNGICIDE Mar 18, 2021 Pending
Array ( [id] => 18018921 [patent_doc_number] => 20220370420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => SPIROCYCLIC 2,3-DIHYDRO-7-AZAINDOLE COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/204089 [patent_app_country] => US [patent_app_date] => 2021-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 97291 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204089 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/204089
Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof Mar 16, 2021 Issued
Array ( [id] => 16991765 [patent_doc_number] => 20210230185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => 7-PHENYLETHYLAMINO-4H-PYRIMIDO[4,5-D][1,3]OXAZIN-2-ONE COMPOUNDS AS MUTANT IDH1 AND IDH2 INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/202515 [patent_app_country] => US [patent_app_date] => 2021-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202515 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/202515
7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors Mar 15, 2021 Issued
Array ( [id] => 18315087 [patent_doc_number] => 11629156 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-18 [patent_title] => 7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors [patent_app_type] => utility [patent_app_number] => 17/202867 [patent_app_country] => US [patent_app_date] => 2021-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17155 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202867 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/202867
7-phenylethylamino-4H-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant IDH1 and IDH2 inhibitors Mar 15, 2021 Issued
Array ( [id] => 18383327 [patent_doc_number] => 11654091 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-05-23 [patent_title] => Hydrophobic topical lotion for swimmers to reduce friction when swimming [patent_app_type] => utility [patent_app_number] => 17/202061 [patent_app_country] => US [patent_app_date] => 2021-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3049 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202061 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/202061
Hydrophobic topical lotion for swimmers to reduce friction when swimming Mar 14, 2021 Issued
Array ( [id] => 17385494 [patent_doc_number] => 20220033346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => METHODS OF TREATING FIBROSIS [patent_app_type] => utility [patent_app_number] => 17/199860 [patent_app_country] => US [patent_app_date] => 2021-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12466 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199860 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/199860
Methods of treating fibrosis Mar 11, 2021 Issued
Array ( [id] => 16945855 [patent_doc_number] => 20210204546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => RERBICIDES [patent_app_type] => utility [patent_app_number] => 17/194537 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14938 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 206 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194537 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/194537
RERBICIDES Mar 7, 2021 Abandoned
Array ( [id] => 16913775 [patent_doc_number] => 20210186867 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => DRUG DELIVERY SYSTEM FOR THE DELIVERY OF ANTIVIRAL AGENTS [patent_app_type] => utility [patent_app_number] => 17/193493 [patent_app_country] => US [patent_app_date] => 2021-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17193493 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/193493
DRUG DELIVERY SYSTEM FOR THE DELIVERY OF ANTIVIRAL AGENTS Mar 4, 2021 Abandoned
Array ( [id] => 17065838 [patent_doc_number] => 20210268053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => FAT ABSORPTION INHIBITING AGENT, FOOD AND DEFATTED SESAME SEEDS, AND METHOD FOR INHIBITING OBESITY [patent_app_type] => utility [patent_app_number] => 17/183646 [patent_app_country] => US [patent_app_date] => 2021-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6124 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17183646 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/183646
Fat absorption inhibiting agent, food and defatted sesame seeds, and method for inhibiting obesity Feb 23, 2021 Issued
Array ( [id] => 16898941 [patent_doc_number] => 20210177857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/183596 [patent_app_country] => US [patent_app_date] => 2021-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44353 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17183596 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/183596
THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING THE SAME Feb 23, 2021 Abandoned
Array ( [id] => 17035039 [patent_doc_number] => 20210251997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => PALIPERIDONE FOR TREATMENT OF DRUG REFRACTORY IRRITABILITY AND AUTISM SPECTRUM DISORDER [patent_app_type] => utility [patent_app_number] => 17/181716 [patent_app_country] => US [patent_app_date] => 2021-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10176 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17181716 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/181716
PALIPERIDONE FOR TREATMENT OF DRUG REFRACTORY IRRITABILITY AND AUTISM SPECTRUM DISORDER Feb 21, 2021 Abandoned
Array ( [id] => 17198745 [patent_doc_number] => 20210338839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-04 [patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY [patent_app_type] => utility [patent_app_number] => 17/181187 [patent_app_country] => US [patent_app_date] => 2021-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35184 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17181187 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/181187
COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY Feb 21, 2021 Abandoned
Array ( [id] => 17065033 [patent_doc_number] => 20210267248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => Nutritional Compositions for Treating Cancer and Side Effects of Cancer Conventional Treatments [patent_app_type] => utility [patent_app_number] => 17/180804 [patent_app_country] => US [patent_app_date] => 2021-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1198 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180804 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/180804
Nutritional Compositions for Treating Cancer and Side Effects of Cancer Conventional Treatments Feb 20, 2021 Abandoned
Array ( [id] => 17035054 [patent_doc_number] => 20210252012 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-19 [patent_title] => Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity [patent_app_type] => utility [patent_app_number] => 17/176018 [patent_app_country] => US [patent_app_date] => 2021-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18987 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176018 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/176018
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity Feb 14, 2021 Abandoned
Menu